DJIA38904.04 307.06
S&P 5005204.34 57.13
NASDAQ16248.52 199.44
Russell 20002060.10 8.70
German DAX18163.94 -238.49
FTSE 1007911.16 -64.73
CAC 408061.31 -90.24
EuroStoxx 505013.35 -57.20
Nikkei 22538992.08 -781.06
Hang Seng16723.92 -1.18
Shanghai Comp3069.30 -5.66
KOSPI2714.21 -27.79
Bloomberg Comm IDX102.90 0.64
WTI Crude-fut91.17 0.01
Brent Crude-fut86.57 1.15
Natural Gas1.79 0.00
Gasoline-fut2.79 -0.01
Gold-fut2345.40 33.50
Silver-fut27.50 0.46
Platinum-fut940.60 -5.50
Palladium-fut1007.40 -23.60
Copper-fut423.60 1.85
Aluminum-spot1815.00 0.00
Coffee-fut212.50 5.75
Soybeans-fut1185.00 5.00
Wheat-fut567.25 11.00
Bitcoin67976.00 304.00
Ethereum USD3328.10 56.27
Litecoin98.71 0.69
Dogecoin0.18 0.00
EUR/USD1.0862 0.0007
USD/JPY151.72 -0.02
GBP/USD1.2678 0.0016
USD/CHF0.9044 -0.0014
USD IDX104.28 0.08
US 10-Yr TR4.4 0.091
GER 10-Yr TR2.406 0.007
UK 10-Yr TR4.064 -0.005
JAP 10-Yr TR0.771 -0.004
Fed Funds5.5 0
SOFR5.32 0
High-rise commercial buildings

Sub Markets

Topics

Direct Investment  + M&As  | 
Brookfield, CDPQ Complete $1.34B Acquisition of Antylia Scientific, Expanding Life Sciences Investment 

Brookfield, CDPQ Complete $1.34B Acquisition of Antylia Scientific, Expanding Life Sciences Investment 

Brookfield Asset Management and Caisse de dépôt et placement du Québec (CDPQ) have completed the acquisition of Antylia Scientific for approximately $1.34 billion, concluding a decade-long ownership by private equity firm GTCR. The transaction marks another significant industrial investment for Brookfield, following its $1.7 billion acquisition of Chemelex earlier this year. 

Based in Vernon Hills, Illinois, Antylia Scientific provides essential consumables and testing equipment for diagnostic, environmental, and life sciences laboratories. Since GTCR’s initial acquisition in 2014—then known as Cole-Parmer Instrument Company in a carve-out from Thermo Fisher Scientific—Antylia has undergone substantial transformation. GTCR supported 15 strategic add-on acquisitions and divested the Masterflex bioprocessing segment in a $2.9 billion sale to Avantor in 2021. 

Brookfield Private Equity Group CEO Anuj Ranjan noted plans to enhance Antylia’s growth through improvements in commercial strategy and procurement. CDPQ’s Martin Longchamps emphasized the company’s role in supporting mission-critical industries. 

Goldman Sachs and Jefferies advised Antylia on the deal, with legal counsel from Kirkland & Ellis. GTCR was advised by J.P. Morgan Securities.  

Connect

Inside The Story

Brookfield Asset ManagementCaisse de dépôt et placement du Québec (CDPQ)Antylia

About Joe Palmisano

Joe Palmisano is Editorial Director for Connect Money, where he brings nearly three decades experience of market insights as a financial journalist, analyst and senior portfolio manager for leading financial publications, advisory firms, and hedge funds. In his role as Editorial Director, Joe is responsible for the selection of content and creation of daily business news covering the financial markets, including Alternative Assets, Direct Investment and Financial Advisory services. Before joining Connect Money, Joe was a financial journalist for the Wall Street Journal, regularly publishing feature stories and trend pieces on the foreign exchange, global fixed income and equity markets. Joe parlayed his experience as a financial journalist into roles as a Senior Research Analyst and Portfolio Manager, writing daily and weekly market analysis and managing a FX and US equity portfolio. Joe was also a contributing writer for industry magazines and publications, including SFO Magazine and the CMT Association. Joe earned a B.S.B.A. in Finance from The American University. He holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.